INSP

Herbert Timothy P.

Known title: CEO and PresidentCIK: 0001737136

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Barclays Starts Coverage of Inspire Medical with Underweight. Barclays has begun coverage of Inspire Medical Systems and assigned an Underweight rating. The firm set a price target of $65 for the stock. This rating follows the recent analyst activity on the company. The stock is currently near its long‑term support level.

this person other insiders at INSP

Transaction History

INSP▲ Buy$0
INSP▼ Sell$239K
INSP▲ Buy$0
INSP▼ Sell$98K
INSP▼ Sell$64K
INSP▼ Sell$1.5M
INSP▲ Buy$0
INSP▲ Buy$0
INSP▼ Sell$163K
INSP▼ Sell—
INSP▼ Sell$0
INSP▼ Sell$2.2M
INSP▼ Sell$274K
INSP▼ Sell$49K
INSP▼ Sell$1.9M
INSP▼ Sell$2.4M
INSP▼ Sell$697K
INSP▼ Sell$311K
INSP▼ Sell$294K
INSP▼ Sell$94K
INSP▲ Buy$0
INSP▲ Buy$226K
INSP▲ Buy$659K
INSP▲ Buy$235K
INSP▲ Buy$9K
INSP▼ Sell$1.6M
INSP▼ Sell$4.6M
INSP▼ Sell$7.8M
INSP▼ Sell$617K
INSP▼ Sell$0
INSP▼ Sell—
INSP▼ Sell$0
INSP▲ Buy$67K
INSP▲ Buy$632
INSP▼ Sell$3.2M
INSP▼ Sell$413K
INSP▼ Sell$5.1M
INSP▼ Sell$720K
INSP▼ Sell$1.9M
INSP▼ Sell$963K
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▲ Buy$286K
INSP▲ Buy$39K
INSP▲ Buy$2K
INSP▲ Buy$14K
INSP▲ Buy$9K
INSP▼ Sell$5.7M
INSP▼ Sell$703K
INSP▼ Sell$517K
INSP▼ Sell$20.7M
INSP▼ Sell$1.6M
INSP▼ Sell$2.1M
INSP▼ Sell$387K
INSP▼ Sell$636K
INSP▼ Sell$174K
INSP▼ Sell$11K
INSP▼ Sell$4.2M
INSP▼ Sell$279K
INSP▼ Sell$8K
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▲ Buy$79K
INSP▼ Sell$0
INSP▼ Sell$0
INSP▲ Buy$11K
INSP▲ Buy$52K
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0
INSP▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.